Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPrime Medicine, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.35 | -$0.25 | -$0.31 |
| Q2 2025 | 10 | -$0.43 | -$0.27 | -$0.35 |
| Q3 2025 | 7 | -$0.30 | -$0.22 | -$0.25 |
| Q4 2025 | 8 | -$0.31 | -$0.20 | -$0.25 |
| Q1 2026 | 4 | -$0.32 | -$0.20 | -$0.24 |
| Q2 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2026 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2026 | 1 | -$0.27 | -$0.27 | -$0.27 |
Prime Medicine, Inc. Earnings Date And Information
Prime Medicine, Inc. last posted its earnings results on Friday, November 7th, 2025. The company reported $-0.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.28 by $0.04. The company had revenue of 1.23 M for the quarter and had revenue of 2.98 M for the year. Prime Medicine, Inc. has generated $-2 earnings per share over the last year ($-1.6516 diluted earnings per share) and currently has a price-to-earnings ratio of -3.04. Prime Medicine, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, February 27th, 2026 based on prior year's report dates.
Prime Medicine, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2025 | Q3 2025 | -$0.28 | -$0.32 | -0.04 | $2.58 M | $1.23 M |
| 08/07/2025 | Q2 2025 | -$0.36 | -$0.41 | -0.05 | $4.18 M | $1.12 M |
| 05/08/2025 | Q1 2025 | -$0.32 | -$0.40 | -0.08 | N/A | $1.45 M |
| 02/28/2025 | Q4 2024 | -$0.37 | -$0.36 | 0.01 | N/A | $2.18 M |
| 11/12/2024 | Q3 2024 | -$0.43 | -$0.44 | -0.01 | $7.09 M | $209.00 K |
| 08/08/2024 | Q2 2024 | -$0.40 | -$0.46 | -0.06 | $1.63 M | $0 |
| 05/10/2024 | Q1 2024 | -$0.45 | -$0.44 | 0.01 | N/A | $591.00 K |
| 03/01/2024 | Q4 2023 | -$0.48 | -$0.67 | -0.19 | N/A | $0 |
| 11/03/2023 | Q3 2023 | -$0.45 | -$0.55 | -0.1 | $1.67 M | $0 |
| 08/07/2023 | Q2 2023 | -$0.42 | -$0.47 | -0.05 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.42 | -$0.44 | -0.02 | N/A | $0 |
| 03/09/2023 | Q4 2022 | -$0.65 | -$0.42 | 0.23 | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$0.37 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.37 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.31 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.72 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.24 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.92 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.04 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prime Medicine, Inc. Earnings: FAQ's
Prime Medicine, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, February 27th, 2026 based offlast year's report dates.
The conference call for Prime Medicine, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Prime Medicine, Inc.'s latest earnings report can be read online.
Prime Medicine, Inc. (:PRME) has a recorded annual revenue of $2.98 M.
Prime Medicine, Inc. (:PRME) has a recorded net income of $-195,882,000.Prime Medicine, Inc. has generated $-1.6516 earnings per share over the last four quarters.
Prime Medicine, Inc. (:PRME) has a price-to-earnings ratio of -3.04 and price/earnings-to-growth ratio is -0.41.